{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:33:01Z","timestamp":1648549981944},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[2009,5,8]],"date-time":"2009-05-08T00:00:00Z","timestamp":1241740800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biol Trace Elem Res"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s12011-009-8387-9","type":"journal-article","created":{"date-parts":[[2009,5,7]],"date-time":"2009-05-07T03:31:25Z","timestamp":1241667085000},"page":"35-40","source":"Crossref","is-referenced-by-count":4,"title":["Antimony Containing Drug and ECG Abnormalities in Children with Visceral Leishmaniasis"],"prefix":"10.1007","volume":"132","author":[{"given":"Lourdes Z\u00e9lia","family":"Zanoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvone Maia","family":"Brustoloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Melnikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo Z.","family":"C\u00f4nsolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,5,8]]},"reference":[{"key":"8387_CR1","unstructured":"State Department of Health of Mato Grosso do Sul. Information and Notification System Diseases. Internal newsletter. August, 2006."},{"key":"8387_CR2","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1128\/AAC.42.5.1076","volume":"42","author":"WL Roberts","year":"1998","unstructured":"Roberts WL, McMurray WJ, Rainey PM (1998) Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime). Antimicrob Agents Chemother 42:1076\u20131082","journal-title":"Antimicrob Agents Chemother"},{"key":"8387_CR3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1590\/S0037-86822002000600014","volume":"35","author":"MA Santos","year":"2002","unstructured":"Santos MA, Marques RC, Farias CA, Vasconcelos DM, Stewart JM, Costa DL, et al. (2002) Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis. Rev Soc Bras Med Trop 35: 629\u2013633","journal-title":"Rev Soc Bras Med Trop"},{"key":"8387_CR4","first-page":"443","volume-title":"Metallotherapeutic drugs and Metal-bases diagnostic agents. The use of metals in medicine","author":"S Yan","year":"2005","unstructured":"Yan S, Jin L, Sun H (2005) Antimony in Medicine. In Gielen M, Tiekink ERT Metallotherapeutic drugs and Metal-bases diagnostic agents. The use of metals in medicine. John Wiley & Sons. Chichester. p. 443\u2013446"},{"key":"8387_CR5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/taap.1995.1006","volume":"130","author":"MA Tirmenstein","year":"1995","unstructured":"Tirmenstein MA, Plews PI, Walker CV, Woolery MD, Wey HE, Toraason MA (1995) Antimony-induced oxidative stress and toxicity in cultured cardiac myocytes. Toxicol Appl Pharmacol 130: 41\u201347","journal-title":"Toxicol Appl Pharmacol"},{"key":"8387_CR6","first-page":"609","volume":"5","author":"LM Volkova","year":"1983","unstructured":"Volkova LM, Kanischeva AS, Udovenko AA, Milhailov YN, Vovna VI (1983) The problem of shortened Sb-Sb distances and polynuclear groups in the compounds of trivalent antimony. Coord Chem 5: 609\u2013615","journal-title":"Coord Chem"},{"key":"8387_CR7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0035-9203(88)90267-2","volume":"82","author":"JD Chulay","year":"1988","unstructured":"Chulay JD, Fleckenstein L, Smith DH (1988) Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans R Soc trop Med Hyg 82: 69\u201372","journal-title":"Trans R Soc trop Med Hyg"},{"key":"8387_CR8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0037-86822000000400009","volume":"33","author":"ACR Saldanha","year":"2000","unstructured":"Saldanha ACR, Romero GAS, Guerra C, Merchan-Hamann E, Macedo VO (2000) Estudo comparativo entre estibogluconato de s\u00f3dio BP 88\u00ae e antimoniato de meglumina no tratamento da leishmaniose cut\u00e2nea II. Toxicidade bioqu\u00edmica e card\u00edaca. Rev Soc Bras Med Trop 33: 383\u2013388","journal-title":"Rev Soc Bras Med Trop"},{"key":"8387_CR9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1590\/S0100-879X1999000300008","volume":"32","author":"ALP Ribeiro","year":"1999","unstructured":"Ribeiro ALP, Drummond JB, Volpini AC, Andrade AC, Passos VMA (1999) Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumina. Braz J Med Biol Res 32: 297\u2013301","journal-title":"Braz J Med Biol Res"},{"key":"8387_CR10","first-page":"465","volume":"87","author":"NC Hepburn","year":"1994","unstructured":"Hepburn NC, Nolan J, Fenn L, Herd RM, Neilson JM, Sutherland GR, et al. (1994) Cardiac effects of sodium stibogluconate: myocardial, electrophysiological and biochemical studies. QJM 87: 465\u2013472","journal-title":"QJM"},{"key":"8387_CR11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","volume":"34","author":"JD Chulay","year":"1985","unstructured":"Chulay JD, Spencer HC, Mugambi M (1985) Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate). Am J Trop Med Hyg 34: 702\u2013709","journal-title":"Am J Trop Med Hyg"},{"key":"8387_CR12","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1124\/mol.105.019281","volume":"69","author":"YA Kuryshev","year":"2006","unstructured":"Kuryshev YA, Wang L, Wible BA, Wan X, Ficker E (2006) Antimony-based antileishmanial compounds prolong the cardiac action potential by an increase in cardiac calcium currents. Mol Pharmacol 69: 1216\u20131225","journal-title":"Mol Pharmacol"},{"key":"8387_CR13","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1152\/ajpcell.1995.268.5.C1195","volume":"268","author":"SN Hatem","year":"1995","unstructured":"Hatem SN, Sweeten T, Vetter V, Morad M (1995) Evidence for presence of Ca2+ channel-gated Ca2+ stores in neonatal human atrial myocytes. Am J Physiol 268: 1195\u20131201","journal-title":"Am J Physiol"},{"key":"8387_CR14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1086\/510860","volume":"195","author":"A Cruz","year":"2007","unstructured":"Cruz A, Rainey PM, Herwaldt BL, Stagni G, Palacios R, Trujillo R, et al. ( 2007) Pharmacokinetics of antimony in children treated for leishmaniasis with meglumine antimoniate. J Infect Dis 195: 602\u2013608","journal-title":"J Infect Dis"},{"key":"8387_CR15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/00034983.1998.11813313","volume":"92","author":"CP Thakur","year":"1998","unstructured":"Thakur CP, Sinha GP, Pandey AK, Kumar N, Kumar P, Hassan SM, et al. (1998) Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases. Ann Trop Med Parasitol 92: 561\u2013569","journal-title":"Ann Trop Med Parasitol"},{"key":"8387_CR16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.4314\/eamj.v78i11.8952","volume":"78","author":"N Berhe","year":"2001","unstructured":"Berhe N, Abraham Y, Hailu A, Ali A, Mengistu G, Tsige K, et al. (2001) Electrocardiographic findings in Ethiopians on pentavalent antimony therapy for visceral leishmaniasis. East Afr Med J 78: 608\u2013610","journal-title":"East Afr Med J"}],"container-title":["Biological Trace Element Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-009-8387-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12011-009-8387-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12011-009-8387-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:30:48Z","timestamp":1559424648000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12011-009-8387-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5,8]]},"references-count":16,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["8387"],"URL":"https:\/\/doi.org\/10.1007\/s12011-009-8387-9","relation":{},"ISSN":["0163-4984","1559-0720"],"issn-type":[{"value":"0163-4984","type":"print"},{"value":"1559-0720","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5,8]]}}}